Skip to main content

Table 5 Adverse events in patients

From: Comparison of the impact of Tripterygium wilfordii Hook F and Methotrexate treatment on radiological progression in active rheumatoid arthritis: 2-year follow up of a randomized, non-blinded, controlled study

  MTX (n = 69) TwFH (n = 69) TwFH + MTX (n = 69)
All 45 (65) 33 (48) 35 (51)
Nausea 18 (26) 9 (13) 17 (25)
Diarrhoea 3 (4) 2 (3) 1 (1)
Abdominal discomfort 13 (19) 9 (13) 11 (16)
Liver dysfunction 13 (19) 5 (7) 8 (12)
Serious Infection 5 (7) 0(0) 2 (3)
Baldness 3 (4) 2 (3) 5 (7)
Ulcer 8 (12) 1 (1) 6 (9)
Irregular menstruation 5 (7) 7 (10) 5 (7)
Anemia 7 (10) 1 (1) 6 (9)
Leucocytopenia 4 (6) 2 (3) 5 (7)
Palpitations 3 (4) 0 (0) 1 (1)
Headache 3 (4) 1 (1) 2 (3)
Fatigue 5 (7) 2 (3) 1 (1)
Weight loss 3 (4) 0 (0) 1 (1)
  1. MTX methotrexate, TwHF Tripterygium wilfordii Hook F
  2. Data are presented as number (percentage)